Biblio

Author Title Type [ Year

]

Filters: Author is Liu, Bo [Clear All Filters]

2019

Liu, B., Lin, L., Riazuddin, S., Zubair, A., Wang, L., Di, L.-J., Li, R., Dong, T.-T., Deng, C.-X., and Tong, W.-M. (2019). PP2ACα deficiency impairs early cortical development through inducing DNA damage in neuroprojenitor cells.Int J Biochem Cell Biol.

2018

Shu, Y., Wu, K., Zeng, Z., Huang, S., Ji, X., Yuan, C., Zhang, L., Liu, W., Huang, B., Feng, Y., et al. (2018). A Simplified System to Express Circularized Inhibitors of miRNA for Stable and Potent Suppression of miRNA Functions.Mol Ther Nucleic Acids13, 556-567.

Lee, S.Chun-Wei, North, K., Kim, E., Jang, E., Obeng, E., Lu, S.X., Liu, B., Inoue, D., Yoshimi, A., Ki, M., et al. (2018). Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations.Cancer Cell34, 225-241.e8.

2016

Pang, J., Wu, Y., Li, Z., Hu, Z., Wang, X., Hu, X., Wang, X., Liu, X., Zhou, M., Liu, B., et al. (2016). Targeting of the Human F8 at the Multicopy rDNA Locus in Hemophilia A Patient-Derived iPSCs Using TALENickases.Biochem Biophys Res Commun.

2015

Liu, H., Du, L., Wang, R., Wei, C., Liu, B., Zhu, L., Liu, P., Liu, Q., Li, J., Lu, S.-L., et al. (2015). High frequency of loss of PTEN expression in human solid salivary adenoid cystic carcinoma and its implication for targeted therapy.Oncotarget.

Jing, W., Smith, A.A., Liu, B., Li, J., Hunter, D.J., Dhamdhere, G., Salmon, B., Jiang, J., Cheng, D., Johnson, C.A., et al. (2015). Reengineering autologous bone grafts with the stem cell activator WNT3A.Biomaterials47C, 29-40.

Ma, W., Wei, X., Gu, H., Li, H., Guan, K., Liu, D., Chen, L., Cao, S., An, D., Zhang, H., et al. (2015). Sensory neuron differentiation potential of in utero mesenchymal stem cell transplantation in rat fetuses with spina bifida aperta.Birth Defects Res A Clin Mol Teratol.

2014

Dhamdhere, G.R., Fang, M.Y., Jiang, J., Lee, K., Cheng, D., Olveda, R.C., Liu, B., Mulligan, K.A., Carlson, J.C., Ransom, R.C., et al. (2014). Drugging a stem cell compartment using wnt3a protein as a therapeutic.Plos One9, e83650.

2013

Leucht, P., Jiang, J., Cheng, D., Liu, B., Dhamdhere, G., Fang, M.Yang, Monica, S.D., Urena, J.J., Cole, W., Smith, L.R., et al. (2013). Wnt3a reestablishes osteogenic capacity to bone grafts from aged animals.J Bone Joint Surg Am95, 1278-88.